Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | RPS6KA4 |
| Upstream (Parents) |
|---|
| (<<) CCND3 → RPS6KA4 |
| (<<) CD4 → RPS6KA4 |
| (<<) DHX9 → RPS6KA4 |
| (<<) FGF5 → RPS6KA4 |
| (<<) HLA-A → RPS6KA4 |
| (<<) KPNA1 → RPS6KA4 |
| (<<) MAP2K1 → RPS6KA4 |
| (<<) PIK3R5 → RPS6KA4 |
| (<<) PIP5K1C → RPS6KA4 |
| (<<) RHOT1 → RPS6KA4 |
| (<<) RNF111 → RPS6KA4 |
| (<<) SMAD5 → RPS6KA4 |
| (<<) SMARCC2 → RPS6KA4 |
| (<<) SOCS5 → RPS6KA4 |
| (<<) TAF9 → RPS6KA4 |
| (<<) TOP2B → RPS6KA4 |
| Downstream (Children) |
|---|
| RPS6KA4 → ALOX15B (>>) |
| RPS6KA4 → ASB1 (>>) |
| RPS6KA4 → CASP5 (>>) |
| RPS6KA4 → EHD1 (>>) |
| RPS6KA4 → GAD1 (>>) |
| RPS6KA4 → KLK5 (>>) |
| RPS6KA4 → MMP9 (>>) |
| RPS6KA4 → NFATC1 (>>) |
| RPS6KA4 → PLA2G3 (>>) |
| RPS6KA4 → PLAUR (>>) |
| RPS6KA4 → SAA4 (>>) |
| RPS6KA4 → SH3TC1 (>>) |
